Bevacizumab Plus Modified FOLFIRINOX in Ovarian, Fallopian Tube, or Primary Peritoneal Mucinous Carcinoma, Single-arm, Phase II Study
Conditions: Mucinous Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer Intervention: Drug: Bevacizumab + modified FOLFIRINOX Sponsor: Yonsei University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Avastin | Cancer | Cancer & Oncology | Carcinoma | Fallopian Tube Cancer | Mucinous Carcinoma | Mucinous Ovarian Cancer | Ovarian Cancer | Ovaries | Research | Study